Market Closed - Nyse 16:00:02 2024-04-12 EDT 5-day change 1st Jan Change
80.13 USD -2.48% Intraday chart for Medtronic plc -5.24% -2.73%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Penumbra, Inc. : The underdog in healthcare Our Logo
Medtronic plc Announces New Advancements in Artificial Intelligence for Endoscopic Care by Unveiling ColonPRO CI
Medtronic plc Announces Collaboration with Modernizing Medicine CI
ModMed & Medtronic Collaborate to Drive Efficiencies in Documenting Colonoscopies Using AI CI
Conflicting signals on rate cuts Our Logo
ANALYST RECOMMENDATIONS : Amex, Cisco, Nasdaq, Wells Fargo, Marathon Petroleum... Our Logo
Transcript : Medtronic plc - Shareholder/Analyst Call
Medtronic plc Announces SMART Trial One-Year Data Demonstrates Medtronic Evolut? Tavr Platform as Optimal Treatment for Severe Aortic Stenosis in Patients with Small Annulus, Which Is Primarily Women CI
Titan Medical Reports Fiscal Year 2023 Results MT
Medtronic Says FDA Approved Transcatheter Aortic Valve Replacement System for Heart Valve Disease MT
Axonics to File for Review After Patent Board Invalidates Claims in Medtronic Case MT
Medtronic to Ask Court to Resume Patent Infringement Case Against Axonics After Favorable Patent Office Ruling MT
Transcript : Medtronic plc Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 08:00 AM
Advance Auto Parts to add three board members as activist investors take stake RE
Advance Auto Parts Has Cooperation Accord With Activist Investors Third Point, Saddle Point; Three Directors Named MT
Medtronic plc Presents New Clinical and Real-World Data on the MiniMed? 780G System from Around the World CI
Medtronic Board Authorizes Incremental $5 Billion for Buybacks; $1.9 Billion Remains Under March 2019 Repurchase Program MT
Medtronic Keeps Fiscal Q4 Cash Dividend at $0.69 a Share, Payable April 12 to Holders of Record March 22 MT
Medtronic plc Approves Cash Dividend for the Fourth Quarter of Fiscal Year 2024, Payable on April 12, 2024 CI
Medtronic plc announces an Increase in Equity Buyback. CI
Tranche Update on Medtronic plc's Equity Buyback Plan announced on June 23, 2017. CI
UBS Raises Medtronic Price Target to $75 From $72, Maintains Sell Rating MT
Deutsche Bank Adjusts Medtronic Price Target to $85 From $79, Maintains Hold Rating MT
Mizuho Securities Raises Price Target on Medtronic to $98 From $95, Maintains Buy Rating MT
Truist Securities Adjusts Price Target on Medtronic to $90 From $87, Keeps Hold Rating MT
Chart Medtronic plc
More charts
Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
80.13 USD
Average target price
94.92 USD
Spread / Average Target
+18.45%
Consensus
  1. Stock Market
  2. Equities
  3. MDT Stock
  4. News Medtronic plc
  5. Sector Update: Health Care Stocks Mixed Pre-Bell Tuesday